Vaccines
Several monomeric and VLP-based subunit vaccines developed. Initial focus on veterinary vaccines with expansion into human pharma following first regulatory approval (targeted 2020)
Learn moreX
Private biotechnology company delivering disruptive technologies for recombinant biologics production using proprietary technologies based on Baculovirus expression systems.
Backed by international VCs and supported by a first in class Advisory Board combining investment and operational experience in developing and leading companies in the veterinary and human health sectors.
Our vision is to transform protein production to enable universal access to biotechnology.
Improved baculovirus vectors
Proprietary Baculovirus expression cassette that allows significant yield increases, long-lasting expression and reduces protein proteolysis.
Learn more
Disruptive manufacturing process
Harnessing the power of insects to act as natural single-use bioreactors with chrysalises from the Trichoplusia ni Lepidopter as production tool.
Learn moreCrisBio® is a patent protected technology that enables productivity of gram/liter levels
- Simple manufacturing
- Almost unlimited linear scalability
- High versatility
- High efficiency: Incorporates TopBac as productivity booster
- Significant savings in production costs
Insect rearing in disposable boxes
Pupae desilking (automated)
Clean pupae
Pupae pick & place (automated)
Baculovirus generation
Automated pupae inoculation
Frozen pupae biomass
Downstream
Purified protein
GMP
RFID-tagged disposable trays
Insect rearing in disposable boxes
Pupae desilking (automated)
Clean pupae
Pupae pick & place (automated)
RFID-tagged disposable trays
Automated pupae inoculation
Baculovirus generation
GMP
Frozen pupae biomass
GMP
Downstream
GMP
Purified protein
GMP
PORTFOLIO
Diagnostics
We develop protein reagents for serological diagnosis of human and animal infectious diseases
Learn more